Mouse Heart Isolation

Perfusion with an oxygenated physiological solution helps preserve myocardial contraction and tissue viability after removal from the animal. Cannulating the aorta provides a route for delivering that solution through the heart, allowing researchers to examine cardiac behavior under controlled ex vivo conditions rather than relying only on observations made after the tissue has been excised.

Rapid exposure and excision help preserve the heart before loss of viability compromises its function. This timing is especially important when the experiment depends on contraction, electrophysiology, metabolism, or molecular responses. The procedure therefore links careful tissue recovery with the quality and interpretability of measurements obtained from the isolated preparation.

Removing the heart from the animal reduces influences from other organs and creates a controlled platform for studying organ-level responses. Investigators can then examine myocardial physiology, ischemia-reperfusion injury, electrophysiology, metabolism, or drug effects while focusing on changes arising within the cardiac preparation rather than across the entire organism.

Under an approved euthanasia protocol, researchers rapidly expose and excise the heart, then may cannulate the aorta and begin perfusion with oxygenated physiological solution. Maintaining the preparation in this state supports contraction and tissue viability for subsequent ex vivo measurements. The exact workflow is organized around preserving the organ quickly and consistently.

This preparation is useful when investigators need to study cardiac responses without contributions from other organs. Applications described for the method include myocardial physiology, ischemia-reperfusion injury, electrophysiology, metabolism, and drug effects. It also offers a controlled setting for examining how experimental conditions alter whole-organ cardiac behavior.

Because the isolated preparation provides a controlled platform, researchers can compare hearts from different genetic or disease models under similar ex vivo conditions. Differences in contraction, electrophysiology, metabolism, injury responses, or drug effects can then be related to model-specific biology. These organ-level findings help connect cellular mechanisms with broader cardiac outcomes.